[1]
2019. EFFICIENCY OF ADJUVANT XELOX CHEMOTHERAPY FOR PATIENTS WITH RESECTABLE GASTRIC IN RUSSIA (SINGLE INSTITUTION RETROSPECTIVE STUDY). Voprosy onkologii. 65, 2 (Feb. 2019), 256–262. DOI:https://doi.org/10.37469/0507-3758-2019-65-2-256-262.